Additionally, activation of the IRE1α‐XBP1 pathway promotes prostate cancer progression via MYC signaling and contributes to hepatocellular carcinoma by enhancing metabolic inflammation [177, 178]. This evidence concerns the gene ERN1 and hepatocellular carcinoma.